About the Ovarian Germ Cell Tumors Session
Ovarian germ cell tumors (OGCTs) are a rare subset of ovarian cancers, originating from the primitive germ cells of the embryonic gonad. They primarily affect adolescents and young women, often presenting with abdominal pain and masses. Research advancements have significantly improved the prognosis for OGCTs, with multimodal treatments combining surgery and chemotherapy proving highly effective. Chemotherapeutic regimens, particularly those including platinum-based compounds, have shown high cure rates even in advanced stages. Ongoing studies focus on minimizing treatment-related toxicity and exploring the molecular genetics of OGCTs to develop targeted therapies. Innovations in fertility preservation are also enhancing quality of life for survivors, addressing a critical concern for this young patient demographic.
Topics Covered in Ovarian Germ Cell Tumors
Dysgerminoma
Yolk Sac Tumor
Serum Tumor Markers
Fertility-Sparing Surgery
Platinum-Based Chemotherapy
Long-Term Survivorship
Related Scientific Sessions at CIOC 2027
Why Attend the Ovarian Germ Cell Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ovarian Germ Cell Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ovarian Germ Cell Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ovarian Germ Cell Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ovarian Germ Cell Tumors Conference 2027 — FAQs
What is the Ovarian Germ Cell Tumors track at CIOC 2027?
The Ovarian Germ Cell Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ovarian Germ Cell Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ovarian Germ Cell Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Ovarian Germ Cell Tumors are all welcome — whether presenting or attending.
Can I present my research in the Ovarian Germ Cell Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ovarian Germ Cell Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ovarian Germ Cell Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
